These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 11751392

  • 1. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
    Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM.
    Cancer Res; 2001 Dec 15; 61(24):8730-6. PubMed ID: 11751392
    [Abstract] [Full Text] [Related]

  • 2. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model.
    Kim SK, Cargioli TG, Machluf M, Yang W, Sun Y, Al-Hashem R, Kim SU, Black PM, Carroll RS.
    Clin Cancer Res; 2005 Aug 15; 11(16):5965-70. PubMed ID: 16115940
    [Abstract] [Full Text] [Related]

  • 3. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.
    Cancer Res; 2002 Dec 01; 62(23):6884-90. PubMed ID: 12460903
    [Abstract] [Full Text] [Related]

  • 4. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, Yung WK, Kang JK.
    Clin Cancer Res; 2000 Aug 01; 6(8):3354-60. PubMed ID: 10955823
    [Abstract] [Full Text] [Related]

  • 5. Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.
    Bello L, Lucini V, Costa F, Pluderi M, Giussani C, Acerbi F, Carrabba G, Pannacci M, Caronzolo D, Grosso S, Shinkaruk S, Colleoni F, Canron X, Tomei G, Deleris G, Bikfalvi A.
    Clin Cancer Res; 2004 Jul 01; 10(13):4527-37. PubMed ID: 15240545
    [Abstract] [Full Text] [Related]

  • 6. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A, Shi Q, Morris D, Wilcox ME, Brasher PM, Rewcastle NB, Shalinsky D, Zou H, Appelt K, Johnston RN, Yong VW, Edwards D, Forsyth P.
    Clin Cancer Res; 1999 Apr 01; 5(4):845-54. PubMed ID: 10213221
    [Abstract] [Full Text] [Related]

  • 7. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM.
    Cancer Res; 1998 Oct 15; 58(20):4654-9. PubMed ID: 9788618
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI, Soroceanu L, Strongin AY.
    Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713
    [Abstract] [Full Text] [Related]

  • 9. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
    Read TA, Farhadi M, Bjerkvig R, Olsen BR, Rokstad AM, Huszthy PC, Vajkoczy P.
    Cancer Res; 2001 Sep 15; 61(18):6830-7. PubMed ID: 11559558
    [Abstract] [Full Text] [Related]

  • 10. Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
    Bello L, Carrabba G, Giussani C, Lucini V, Cerutti F, Scaglione F, Landré J, Pluderi M, Tomei G, Villani R, Carroll RS, Black PM, Bikfalvi A.
    Cancer Res; 2001 Oct 15; 61(20):7501-6. PubMed ID: 11606386
    [Abstract] [Full Text] [Related]

  • 11. Long-term inhibition of glioma growth by systemic administration of human PEX.
    Pluderi M, Lucini V, Caronzolo D, Pannacci M, Costa F, Carrabba G, Giussani C, Grosso S, Colleoni F, Scaglione F, Villani R, Bikfalvi A, Bello L.
    J Neurosurg Sci; 2003 Jun 15; 47(2):69-78. PubMed ID: 14618134
    [Abstract] [Full Text] [Related]

  • 12. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T, Guan M, Xu C, Chen Y, Lu Y.
    Life Sci; 2007 Sep 29; 81(16):1256-63. PubMed ID: 17919663
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K, Brockmann MA, Eckerich C, Bohlen P, May C, Mangold U, Fillbrandt R, Westphal M.
    Clin Cancer Res; 2005 Jul 01; 11(13):4934-40. PubMed ID: 16000592
    [Abstract] [Full Text] [Related]

  • 14. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.
    Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W.
    Cancer Res; 2001 Mar 15; 61(6):2744-50. PubMed ID: 11289157
    [Abstract] [Full Text] [Related]

  • 15. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
    Lamfers ML, Gianni D, Tung CH, Idema S, Schagen FH, Carette JE, Quax PH, Van Beusechem VW, Vandertop WP, Dirven CM, Chiocca EA, Gerritsen WR.
    Cancer Res; 2005 Oct 15; 65(20):9398-405. PubMed ID: 16230403
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
    Perri SR, Nalbantoglu J, Annabi B, Koty Z, Lejeune L, François M, Di Falco MR, Béliveau R, Galipeau J.
    Cancer Res; 2005 Sep 15; 65(18):8359-65. PubMed ID: 16166313
    [Abstract] [Full Text] [Related]

  • 17. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
    Chen DL, Ping YF, Yu SC, Chen JH, Yao XH, Jiang XF, Zhang HR, Wang QL, Bian XW.
    Biochem Biophys Res Commun; 2009 Apr 10; 381(3):448-52. PubMed ID: 19233142
    [Abstract] [Full Text] [Related]

  • 18. Increased levels of tissue endostatin in human malignant gliomas.
    Morimoto T, Aoyagi M, Tamaki M, Yoshino Y, Hori H, Duan L, Yano T, Shibata M, Ohno K, Hirakawa K, Yamaguchi N.
    Clin Cancer Res; 2002 Sep 10; 8(9):2933-8. PubMed ID: 12231538
    [Abstract] [Full Text] [Related]

  • 19. Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer.
    Bandyopadhyay A, Wang L, López-Casillas F, Mendoza V, Yeh IT, Sun L.
    Prostate; 2005 Apr 01; 63(1):81-90. PubMed ID: 15468171
    [Abstract] [Full Text] [Related]

  • 20. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF, Ellis LM.
    Cancer Res; 2003 May 01; 63(9):2079-87. PubMed ID: 12727823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.